The impact of EGFR stimulation and inhibition on BPDE induced DNA fragmentation in oral/oropharyngeal mucosa in vitro

被引:6
作者
Baumeister, Philipp [1 ]
Heinrich, Katharina [1 ]
Maerte, Melanie [1 ]
Reiter, Maximilian [1 ]
Schwenk-Zieger, Sabina [1 ]
Harreus, Ulrich [1 ]
机构
[1] Univ Munich, Dept Otorhinolaryngol & Head & Neck Surg, D-80539 Munich, Germany
关键词
EGFR; Mutagen sensitivity; BPDE; Comet assay; TRANSFORMING-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR EXPRESSION; MINI-ORGAN CULTURES; NECK-CANCER; COMET ASSAY; DIOL EPOXIDE; FACTOR-ALPHA; DRUG-RESISTANCE; TISSUE-CULTURES;
D O I
10.1016/j.oraloncology.2011.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Still, the vast majority of head and neck squamous cell carcinoma (HNSCC) can be linked to the "traditional" risk factors tobacco smoke and alcohol consumption. These tumors are believed to be the results of multiple years of carcinogenic impact on upper aerodigestive tract mucosa. The frequent observation, that one patient suffers from several synchronous cancers, multiple local recurrences, and second primary tumors led to the concept of field cancerization, first introduced by Slaughter and colleagues in 1953. As underlying molecular events, genetic instability, loss of heterozygosity, amplification, deletion, up-and down-regulation of oncogenes and/or tumor suppressor genes were revealed. One of the best studied oncogenic features of head and neck carcinogenesis are high expression levels of epidermal growth factor receptor (EGFR). Enhanced expression of the receptor was detected in histologically normal mucosa from HNSCC patients and increasing levels during the progress from hyperplasia to dysplastic lesion and invasive carcinoma were demonstrated. Whereas nearly all of our knowledge about EGFR biology in HNSCC is based on preclinical and clinical studies investigating receptor inhibitors, little is known about cause and function of EGFR in premalignant mucosa. In this study we show, that EGFR stimulation significantly decreases carcinogen induced DNA damage in normal mucosa from HNSCC patients and that this effect is completely abrogated adding an anti-EGFR antibody before stimulation, while there was no effect in non-tumor controls. The effect of EGFR inhibition was contrary. In non-tumor controls, blocking the receptor with an antibody significantly decreased DNA damage, whereas in cases no effect was seen. Our results indicate an important role of the receptor during chemical carcinogenesis. On the basis of this study we suppose, that increasing EGFR levels during head and neck carcinogenesis can be interpreted as a physiological response to permanent carcinogen impact on the mucosa. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1141 / 1147
页数:7
相关论文
共 37 条
[1]  
Ang KK, 2002, CANCER RES, V62, P7350
[2]   Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action [J].
Baird, WM ;
Hooven, LA ;
Mahadevan, B .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 45 (2-3) :106-114
[3]   Transforming Growth Factor Alpha Stimulation of Mucosal Tissue Cultures from Head and Neck Squamous Cell Carcinoma Patients Increases Chemoresistance to Cisplatin [J].
Baumeister, Philipp ;
Reiter, Maximilian ;
Schwenk-Zieger, Sabina ;
Harreus, Ulrich .
CHEMOTHERAPY, 2010, 56 (04) :268-274
[4]   Transforming Growth Factor-alpha reduces carcinogen-induced DNA damage in mini-organ cultures from head-and-neck cancer patients [J].
Baumeister, Philipp ;
Schwenk-Zieger, Sabina ;
Reiter, Maximilian ;
Welz, Christian ;
Harreus, Ulrich .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2009, 677 (1-2) :42-45
[5]   Epigallocatechin-3-gallate reduces DNA damage induced by benzo[a]pyrene diol epoxide and cigarette smoke condensate in human mucosa tissue cultures [J].
Baumeister, Philipp ;
Reiter, Maximilian ;
Kleinsasser, Norbert ;
Matthias, Christoph ;
Harreus, Ulrich .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2009, 18 (03) :230-235
[6]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[7]  
Braakhuis BJM, 2003, CANCER RES, V63, P1727
[8]   The comet assay: topical issues [J].
Collins, Andrew R. ;
Oscoz, Amaia Azqueta ;
Brunborg, Gunnar ;
Gaivao, Isabel ;
Giovannelli, Lisa ;
Kruszewski, Marcin ;
Smith, Catherine C. ;
Stetina, Rudolf .
MUTAGENESIS, 2008, 23 (03) :143-151
[9]   Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium [J].
Conway, David I. ;
Hashibe, Mia ;
Boffetta, Paolo ;
Wunsch-Filho, Victor ;
Muscat, Joshua ;
La Vecchia, Carlo ;
Winn, Deborah M. .
ORAL ONCOLOGY, 2009, 45 (09) :743-746
[10]   The comet assay in human biomonitoring: gene-environment interactions [J].
Dusinska, Maria ;
Collins, Andrew R. .
MUTAGENESIS, 2008, 23 (03) :191-205